Beta Bionics, Inc Common Stock

Quarterly Financials

Values in thousands 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Revenue
$23,238
$17,639
$20,440
$16,705
Gross Profit
12,503
8,971
11,689
8,914
EBITDA
-19,872
-18,038
-17,579
-10,670
EBIT
-20,525
-18,642
-18,108
-10,977
Net Income
-16,869
-28,656
-18,108
-9,736
Net Change In Cash
23,238
17,639
20,440
16,705
Free Cash Flow
-15,373
-20,308
-14,840
-11,534
Cash
35,075
42,454
30,432
17,481
Basic Shares
43,390
30,714
43,348
6,264

Annual Financials

Values in thousands 2024-12-31 2023-12-31 2022-12-31
Revenue
$65,124
$11,995
$179
Gross Profit
35,888
6,308
179
EBITDA
-44,100
-34,624
-63,399
EBIT
-45,251
-35,850
-64,744
Net Income
-54,756
-44,099
-64,751
Net Change In Cash
65,124
11,995
179
Free Cash Flow
-51,668
-32,847
-60,980
Cash
30,432
26,566
27,675
Basic Shares
6,365
5,303
4,997

Earnings Calls

Quarter EPS
2025-06-30
-$0.38
2025-03-31
-$0.66
2024-12-31
-$0.41